Hematologic Studies: RBC Survival, Sequestration & Blood Volume⁵¹Cr-labeled RBC · ¹²⁵I-albumin
Cr-51 red-cell survival, splenic sequestration, and blood-volume measurement
Quick Answer
Classic nuclear-hematology studies use Cr-51-labeled autologous red cells and I-125-albumin to quantify red-cell survival, splenic sequestration, and blood volume — mostly historical now (largely superseded by lab methods) but retained on the curriculum and occasionally used. Cr-51 RBC survival measures red-cell lifespan (normal apparent T½ ~25–35 days, shortened in hemolysis); surface counting over spleen vs liver gives a spleen:liver sequestration ratio that helps predict benefit from splenectomy; and blood-volume measurement (Cr-51 red-cell mass ± I-125-albumin plasma volume) distinguishes true (absolute) erythrocytosis of polycythemia vera from relative (spurious) polycythemia.
Red-Cell Survival (Cr-51)
- Method: the patient's RBCs are labeled with Cr-51 (sodium chromate), reinjected, and blood-sample counts are followed over ~1–3 weeks; Cr-51 elutes from cells over time, so the measured apparent T½ (~25–35 days) is shorter than the true ~120-day lifespan (a known correction factor).
- Use: documents and quantifies hemolysis; a shortened survival confirms reduced red-cell lifespan.
Splenic Sequestration (Surface Counting)
- Method: external surface counting over the spleen, liver, and precordium during the survival study yields a spleen:liver ratio and its rise over time.
- Use: a high or rising spleen:liver ratio indicates the spleen is the dominant site of red-cell destruction — historically used to predict response to splenectomy in hemolytic anemias (e.g., hereditary spherocytosis, some autoimmune hemolysis).
Blood Volume
- Red-cell mass: measured directly with Cr-51-labeled RBCs (dilution principle).
- Plasma volume: measured with I-125-albumin; total blood volume and hematocrit-derived values follow.
- Use: the reference method to separate absolute erythrocytosis (true increase in red-cell mass — polycythemia vera) from relative/apparent polycythemia (contracted plasma volume, normal red-cell mass) — a distinction lab hematocrit alone cannot make.
Related Splenic Imaging
Heat-damaged (denatured) Tc-99m-RBC imaging is the modern splenic-specific study (accessory spleen, splenosis) — see the liver–spleen page. Sulfur-colloid colloid shift reflects RES/portal physiology.
Interpretation & Reporting
- RBC survival: report apparent T½ (with the elution caveat) — shortened = hemolysis.
- Sequestration: report the spleen:liver ratio trend and its splenectomy implication.
- Blood volume: report red-cell mass and plasma volume, classifying true vs relative erythrocytosis.
Common Pitfalls
- Reading the Cr-51 apparent T½ (~25–35 d) as the true red-cell lifespan (Cr-51 elutes — apply the correction).
- Over-relying on hematocrit alone to diagnose polycythemia (needs red-cell mass).
- These methods are largely historical/superseded — interpret in the context of modern hematology.
Board Pearls
Cr-51-labeled RBCs measure red-cell survival (apparent T½ ~25–35 d, shortened in hemolysis — the value is shorter than true lifespan because Cr-51 elutes) and, with surface counting, a spleen:liver sequestration ratio that historically predicts splenectomy benefit. Blood-volume measurement (Cr-51 red-cell mass ± I-125-albumin plasma volume) separates true polycythemia vera (absolute red-cell mass ↑) from relative polycythemia.
A high/rising spleen:liver ratio points to the spleen as the dominant red-cell-destruction site (favoring splenectomy in hemolytic anemia). Hematocrit alone cannot distinguish absolute from relative erythrocytosis — red-cell mass does.
These studies are largely historical (superseded by modern lab methods) but remain syllabus content. The modern splenic study is heat-damaged Tc-99m-RBC imaging (accessory spleen/splenosis; see liver–spleen). The Schilling test (B12 absorption) is another obsolete nuclear-hematology study of historical interest only.
Related Pages
- Related: liver–spleen & hemangioma imaging (heat-damaged RBC, colloid shift); tracer: Tc-99m-labeled RBC.
Figure / Diagram Suggestions
- A Cr-51 survival curve with the elution-corrected vs apparent T½.
- A spleen:liver surface-counting schematic (sequestration ratio).
- An absolute vs relative polycythemia red-cell-mass/plasma-volume comparison.
Self-Check
Q1. Why is the Cr-51 apparent red-cell survival (~25–35 days) shorter than the true ~120-day lifespan?
Answer: Cr-51 elutes from the red cells over time, so the measured apparent half-life underestimates true survival (a known correction applies).
Q2. What does a high or rising spleen:liver ratio on surface counting indicate?
Answer: The spleen is the dominant site of red-cell destruction — historically used to predict benefit from splenectomy.
Q3. How does blood-volume measurement distinguish polycythemia vera from relative polycythemia?
Answer: PV shows a true increase in red-cell mass (Cr-51); relative polycythemia has a normal red-cell mass with contracted plasma volume — hematocrit alone cannot separate them.
Q4. What is the modern splenic-specific imaging study, and for what?
Answer: Heat-damaged (denatured) Tc-99m-RBC imaging — for accessory spleen and splenosis.
Evidence & sources
https://nuc.med/nuclear-hematology-studies/ Report an issue